Evidence map›Paper›PMID 40810927›Full record

SynthesisSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2025

Management of patients with cancer pain: an evaluation of AGREE II-based clinical practice guidelines.

Xia Lin, Jiaying Huang, Wanxian Zeng, Shaowei Zhuang, Jing Yang, Jianlei Zheng

Abstract readSystematic Review
PubMed Publisher
In one paragraph

Synthesis in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xia Lin *Department of Pharmacy, Union Hospital, Fujian Medical University, Fuzhou, China.
Jiaying Huang *Department of Pharmacy, Union Hospital, Fujian Medical University, Fuzhou, China.
Wanxian ZengDepartment of Pharmacy, Union Hospital, Fujian Medical University, Fuzhou, China.
Shaowei ZhuangDepartment of Pharmacy, Union Hospital, Fujian Medical University, Fuzhou, China.
Jing Yang *Department of Pharmacy, Union Hospital, Fujian Medical University, Fuzhou, China. Jiangyang@fjmu.edu.cn.
Jianlei Zheng *Department of Pharmacy, Union Hospital, Fujian Medical University, Fuzhou, China. 15960125857@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo systematically evaluate the clinical practice guidelines for cancer pain management published during 2014-2024, analyze the quality characteristics and recommendations of existing guidelines, and provide an evidence-based basis for the development and implementation of standardized clinical practice guidelines for pain management.

methodsA systematic search of PubMed, OVID, Cochrane Library, China National Knowledge, and other databases was performed to include guidelines related to the management of cancer pain patients. The Appraisal of Guidelines for Research and Evaluation Tool (AGREE II) was used to evaluate the quality of the literature that met the inclusion criteria and to determine the guideline recommendation level.

resultsA total of 23 guidelines were included. AGREE II evaluation results demonstrated that the average scores across six domains were as follows: scope and purpose (97.22%), participants involved in guideline development (73.67%), rigor of development (70.32%), clarity (85.51%), applicability (39.22%), and independence of compilation (81.16%). There were 4 grade A recommendations, 19 grade B recommendations, and no grade C guidelines. The guideline recommendations primarily encompassed five core areas: cancer pain diagnosis, management of special populations, principles of pain management, intervention measures, and pharmaceutical services.

conclusionsExisting clinical practice guidelines for cancer pain management are generally of high quality, but there is still much room for improvement in terms of applicability. It is recommended to optimize the development, dissemination, and application of the guidelines, taking into full consideration the individualized characteristics of patients, in order to further improve the quality of clinical practice in cancer pain management.

Indexed as

Cancer PainNeoplasmsPain ManagementPractice Guidelines as TopicHumansCancer pain managementClinical guidelinesEvidence-based medicineSystematic evaluation

Identifiers

PMID40810927

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.